EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis

Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, Tatsuya Sato, Keisuke Endo, Itaru Hosaka, Nagisa Hanawa, Naoya Sakamoto, Masato Furuhashi iD

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Kazuma Mori und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim New nomenclature of steatotic liver disease (SLD) including metabolic dysfunction‐associated SLD (MASLD), MASLD and increased alcohol intake (MetALD), and alcohol‐associated liver disease (ALD) has recently been proposed. We investigated clustering analyses to decipher the complex landscape of SLD pathologies including the former nomenclature of nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction‐associated fatty liver disease (MAFLD).

Methods

Japanese individuals who received annual health checkups including abdominal ultrasonography ( n = 15 788, men/women: 10 250/5538, mean age: 49 years) were recruited.

Results

The numbers of individuals with SLD, MASLD, MetALD, ALD, NAFLD, and MAFLD were 5603 (35.5%), 4227 (26.8%), 795 (5.0%), 324 (2.1%), 3982 (25.8%), and 4946 (31.3%), respectively. Clustering analyses using t‐distributed stochastic neighbor embedding and K‐means to visually represent interconnections in SLDs uncovered five cluster formations. MASLD and NAFLD mainly shared three clusters including (i) low alcohol intake with relatively low‐grade obesity; (ii) obesity with dyslipidemia; and (iii) dysfunction of glucose metabolism. Both MetALD and ALD displayed one distinct cluster intertwined with alcohol consumption. MAFLD widely shared all of the five clusters. In machine learning‐based analyses using algorithms of random forest and extreme gradient boosting and receiver operating characteristic curve analyses, fatty liver index (FLI), calculated by body mass index, waist circumference, and levels of γ‐glutamyl transferase and triglycerides, was selected as a useful feature for SLDs.

Conclusions

The new nomenclature of SLDs is useful for obtaining a better understanding of liver pathologies and for providing valuable insights into predictive factors and the dynamic interplay of diseases. FLI may be a noninvasive predictive marker for detection of SLDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseFatty LiverHumansFemaleMaleMiddle AgedCluster AnalysisAdultTerminology as TopicObesityAlcohol DrinkingLiver Diseases, AlcoholicUltrasonographyJapan

Stichwörter der Autor:innen

clusteringmachine learningmetabolic dysfunction‐associated fatty liver disease (MAFLD)metabolic dysfunction‐associated steatotic liver disease (MASLD)nonalcoholic fatty liver disease (NAFLD)

Autor:innen und Institutionen

  • Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
  • Department of Neurosurgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Cardiovascular Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic, Sapporo, Japan.

ORCID-Profile: Masato Furuhashi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Mori, K., Akiyama, Y., Tanaka, M., Sato, T., Endo, K., Hosaka, I., Hanawa, N., Sakamoto, N., & Furuhashi, M. (2024). Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16552

Vancouver

Mori K, Akiyama Y, Tanaka M, Sato T, Endo K, Hosaka I, et al. Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16552

BibTeX
@article{Mori2024,
  author = {Mori, Kazuma and Akiyama, Yukinori and Tanaka, Marenao and Sato, Tatsuya and Endo, Keisuke and Hosaka, Itaru and Hanawa, Nagisa and Sakamoto, Naoya and Furuhashi, Masato},
  title = {Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16552}
}
Kostenlos starten →